Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
Paras Healthcare plans ₹1,800 crore IPO, files draft papers with Sebi
Paras Healthcare Ltd, which operates hospitals under the 'Paras Health' brand, has filed preliminary papers with capital markets regulator Sebi to raise up to Rs 1,800 crore through an initial public offering (IPO). The proposed IPO comprises a fresh issue of equity shares aggregating up to Rs 500 crore and an Offer-For-Sale (OFS) of equity shares worth up to Rs 1,300 crore by the selling shareholder, according to the draft red herring prospectus (DRHP) filed on Thursday. Those selling shares include promoter Dharminder Kumar Nagar and other investors. The Gurugram-based company intends to utilise the proceeds from the fresh issue towards prepayment or repayment of certain outstanding borrowings, investment in its wholly-owned subsidiary PMHPL for its debt payment, and for general corporate purposes. Paras Healthcare is a clinical specialty-led hospital platform providing tertiary and quaternary healthcare services through a network of eight hospitals with an aggregate capacity of
Nifty 50, Sensex May Open Muted Ahead of RBI Policy; Titan, Aurobindo Pharma, Groww in Focus - Dalal Street Investment Journal
Nifty 50, Sensex May Open Muted Ahead of RBI Policy; Titan, Aurobindo Pharma, Groww in FocusDalal Street Investment Journal
Stocks in news: Alkem Labs, Vedanta, Canara Bank, NHPC, Adani Ports
Markets closed higher on weekly expiry day despite volatility, with Nifty showing signs of recovery but facing resistance around 23,800-24,000. Key stocks like Alkem Labs, Vedanta, Canara Bank, NHPC, and Adani Ports are in focus due to significant corporate developments including block deals, ED visits, capital raising plans, oversubscribed OFS, and strong cargo volumes.
Buy, Sell Or Hold: Wockhardt, Sagility, UCO Bank, Groww And Sammaan Capital — Ask Profit
Market experts shared buy, sell and hold recommendations for an array of stocks.
Sensex falls 70 points, Nifty below 23,900 as US-Iran tensions simmer
Indian stock markets opened lower on Wednesday. Sensex and Nifty saw minor declines. Investors are watching US strikes on Iran and their effect on peace deal hopes. Broader markets are performing better. India VIX, a volatility measure, dropped. Top Sensex losers included HDFC Bank and Infosys. Sun Pharma shares led gains. Midcap and smallcap indices saw small gains.
Cotec Healthcare, Deepa Jewellers receive SEBI's nod to float IPOs
Cotec Healthcare and Deepa Jewellers get SEBI approval for IPOs, plan fresh issues and OFS to fund capacity expansion, working capital and general corporate needs, to list on BSE and NSE
Pharma, healthcare stocks drag markets amid volatility; Nifty and Sensex close week in green
The equity benchmark indices closed in the green on Friday (May 22) but could not fully hold intraday gains, with Sensex rising 232 points to 75,415 and Nifty gaining 65 points to 23,719.
Q4 Results LIVE Updates: Max Health shares decline 7%, Honasa Consumer up 7%; Hindalco report today
Q4 Results Live Update: Another busy earnings week ends with three Nifty names - Sun Pharma, Eicher Motors and Hindalco reporting their results today, along with broader market names like Torrent Pharma, Fortis Healthcare, DAM Capital, Colgate-Palmolive, IRCON International, Jubilant Pharmova, Minda Corp, and many others. LG, LIC, GAIL, ITC, will also be reacting to their results reported on Thursday.
INR recovers from historic lows as oil pulls back; RBI announces $5 billion US Dollar/INR swap auction to defend rupee
The Indian rupee recovered well in opening trades on Thursday as global investors noted a slight pullback in crude oil prices over the recent comments on a potential final stage of the US-Iran conflict. INR opened at Rs 96.25 per dollar and hit a high of 96.05 so far during the day. Yesterday, the counter ended near the next critical level of 96.86, a new historic low. Meanwhile, in a major structural intervention to stabilise domestic financial markets, the Reserve Bank of India (RBI) has announced a $5 billion USD/INR buy-sell swap auction. Scheduled to take place next week on Tuesday, May 26, the central banks move is specifically engineered to inject durable, long-term Rupee liquidity into the commercial banking system. The Indian Rupee has faced persistent downward pressure, depreciating significantly against the American greenback in recent weeks due to ongoing global macroeconomic uncertainties and shifting foreign capital flows. By deploying this specialised monetary tool, ...